Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Rani Therapeutics Holdings, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Michelle Gilson (Form 8-K filed 2026-08-04). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Ra Capital Management, L.P. (filed 2026-08-14).
Who is behind it
Rani Therapeutics Holdings, Inc.: incorporated in California; business address in San Jose, California; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-08-14).
Officers and directors, each with the role and the filing that names them:
- Talat Imran: Executive Officer, Director (Form D, 2025-11-10)
- Svai Sanford: Executive Officer (Form D, 2025-11-10)
- Mir Imran: Director (Form D, 2025-11-10)
- Dennis Ausiello: Director (Form D, 2025-11-10)
- Jean-Luc Butel: Director (Form D, 2025-11-10)
- Mir Hashim: Executive Officer (Form D, 2025-11-10)
- Lisa Rometty: Director (Form D, 2025-11-10)
- Abraham Bassan: Director (Form D, 2025-11-10)
- Vasudev Bailey, M.D.: Director (Form D, 2025-11-10)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Ra Capital Management, L.P. | 9.9% |
| Schedule 13G/A, 2026-07-31 | Vanguard Capital Management | 4.49% |
| Schedule 13D/A, 2026-05-28 | Samsara Biocapital, L.P. | 9.9% |
| Schedule 13G/A, 2026-05-15 | Symbiosis Capital Partners, LLC | 4.4% |
| Schedule 13G, 2026-04-30 | Vanguard Capital Management | 5.12% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G, 2026-02-13 | Awm Investment Company, Inc. | 9.9% |
| Schedule 13G, 2026-02-12 | Symbiosis Capital Partners, LLC | 6.5% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-08-04 | Michelle Gilson | appointed | ||
| Form 8-K, 2026-05-15 | Svai Sanford | Chief Financial Officer | departed |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-11-10 | $60.26M | $60.26M |
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/rani-therapeuticsLast updated 2026-10-18
Primary record: Schedule 13G/A, 2026-08-14 · Form D, 2025-11-10 · Form 8-K, 2026-08-04 · Form 8-K, 2026-05-15
Who owns Rani Therapeutics Holdings, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/rani-therapeutics